Eli Lilly I7X-MC-LLCF
Back to Drug Development Trials
![]()
Drug Development Trials
About the trial
Effect of LY3202626 on Alzheimer’s Disease Progression as Measured by Cerebral 18F-AV1451 Tau-PET in Mild Alzheimer’s Disease Dementia
